CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 102-110

  Deeths, Matthew J ^a   Kedl, Ross M ^a   Mescher, Matthew F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 7; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033168651     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.163.1.102     Document Type: Article

References (48)

1. + cells after a transient response to antigen. Eur. J. Immunol. 23:1963.
2. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056.
3. + T cells. J. Exp. Med. 184:863.
4. + T cell help. J. Exp. Med. 186:65.
5. Ossendorp, F., E. Mengede, M. Camps, R. Filius, and C. J. M. Melief. 1998. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibilty complex class II negative tumors. J. Exp. Med. 187:693.
6. Azuma, M., M. Cayabyab, D. Buck, J. Phillips, and L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353.
7. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791.
8. + T cells. Eur. J. Immunol. 27:598.
9. + T cells. Proc. Natl. Acad. Sci. USA 93: 14736.
10. + T cells are poorly costimulated by ICAM-1. Eur. J. Immunol. 29:45.
11. Kyburz, D., P. Aichele, D. Speiser, H. Hengartner, R. Zinkernagel, and H. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956.
12. Rocha, B., and H. von Boehmer. 1991. Peripheral selection of the T cell repertoire. Science 251:1225.
13. Rocha, B., C Tanchot, and H. vonBoehmer. 1993. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177:1517.
14. + T cells by staphylococcal enterotoxin B. J. Exp. Med. 172:1091.
15. Jenkins, M., and R. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
16. Quill, H., and R. Schwartz. 1987. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative non-responsiveness. J. Immunol. 138:3704.
17. Mueller, D., M. Jenkins, and R. Schwartz. 1989. Clonal expansion vs functional clonal inactivation. Annu. Rev. Immunol. 7:445.
18. + T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 251:1228.
19. Sprent, J., and M. Schaefer. 1989. Antign-presenting cells for unprimed T cells. Immunol. Today 10:17.
20. Hogquist, K., S. Jameson, W. Heath, J. Howard, M. Bevan, and F. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
21. Kuhlman, P., V. Moy, B. Lollo, and A. Brian. 1991. The accessory function of murine ICAM-1 in T lymphocyte activation: contributions of adhesion and co-activation. J. Immunol. 146:1773.
22. Curtsinger, J., M. J. Deeths, P. Pease, and M. F. Mescher. 1997. Artificial cell surface constructs for studying receptor-ligand contributions to lymphocyte activation. J. Immunol. Methods 209:47.
23. + T cells upon in vivo stimulation with allogeneic tumor. J. Immunol. 159:650.
24. + T cell response. J. Immunol. 161:674.
25. Sha, W., C. Nelson, R. Newberry, D. Kranz, J. Russell, and D. Loh. 1988. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice. Nature 335:271.
26. Liu, B., E. R. Podack, J. P. Allison, and T. R. Malek. 1996. Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors. J. Immunol. 156:1117.
27. Akbar, A. N., N. J. Borthwick, R. G. Wickremasinghe, P. Panayiotidis, D. Pilling, M. Bofill, S. Krajewski, J. C. Reed, and M. Salmon. 1996. Interluekin 2 receptor common γ-chain signaling cytokines regulate activated T cell apoptosis inresponse to growth factor withdrawl: selective induction of anti-apoptotic (bcl-2, bcl-xl) but not proapoptotic (bax, bcl-xs) gene expression. Eur. J. Immunol. 26: 294.
28. +) to TCR/ CD8 signaling in response to antigen. J. Immunol. 160:3236.
29. Ni, H.-T., M. J. Deeths, W. Li, D. L. Mueller, and M. F. Mescher. 1999. Signaling pathways activated by LFA-1-dependent costimulation. J. Immunol. In press.
30. Zanders, E. D., J. R. Lamb, M. Feldmann, N. Green, and P. C. L. Beverley. 1983. Tolerance of T-cell clones is associated with membrane antigen changes. Nature 303:625.
31. Valitutti, S., S. Muller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.
32. Walunas, T., C. Bakker, and J. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
33. Krummel, M., and J. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
34. Tivol, E., F. Borriello, A. Schweitzer, W. Lynch, J. Bluestone, and A. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
35. Waterhouse, P., J. Penninger, E. Timms, A. Wakeham, A. Shaninian, K. Lee, C. Thompson, H. Griesser, and T. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985.
36. Andris, F., M. Van Mechelen, F. De Mattia, E. Baus, J. Urbain, and O. Leo. 1996. Induction of T cell unresponsiveness by anti-CD3 Abs occurs independently of co-stimulatory functions. Eur. J. Immunol. 26:1187.
37. Malvey, E.-N., D. G. Telander, T. L. Vanasek, and D. L. Mueller. The role of clonal anergy in the avoidance of autoimmunity: inactivation of autocrine growth without loss of effector function. Immunol. Rev. 165:301.
38. Hollsberg, P., V. Batra, A. Dressel, and D. A. Hafler. 1996. Induction of anergy in CD8 T cells by B cell presentation of antigen. J. Immunol. 157:5269.
39. Ucker D., J. Meyers, and P. Obermiller. 1992. Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J. Immunol. 149:1583.
40. Radvanyi, L. G., G. B. Mills, and R. G. Miller. 1993. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J. Immunol. 150:5704.
41. Wesselborg, S., O. Janssen, and D. Kabelitz. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338.
42. Liu, Y., and C. A. Janeway, Jr. 1990. Interferon γ plays a critical role in induced cell death of effector T cell: A possible third mechanism of self-tolerance. J. Exp. Med. 172:1735.
43. Krummel, M., and J. Allison. 1995. CD28 and CTLA-4 deliver opposing signals which regulate the response of T cells to stimulation. J. Exp. Med. 182:459.
44. + T cells. Science 271:1276.
45. + T cells. Science 271:1272.
46. + T cells. J. Immunol. 144:3980.
47. + cells in sustaining lyphocyte proliferation during lyphocytic choriomengitis virus infection. J. Immunol. 146:1955.
48. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992. Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123.